7 pending office actions • 3 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Vertex Pharmaceuticals Incorporated | 5 |
| Vertex Pharmaceuticals Incorporated | 1 |
| Alpine Immune Sciences, Inc. | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18566282 | N-(HYDROXYALKYL (HETERO)ARYL) TETRAHYDROFURAN CARBOXAMIDE ANALOGS AS MODULATORS OF SODIUM CHANNELS | Vertex Pharmaceuticals Incorporated | JAVANMARD, SAHAR | 1622 | Non-Final OA | Dec 01, 2023 |
| 18566297 | SUBSTITUTED TETRAHYDROFURAN-2-CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS | Vertex Pharmaceuticals Incorporated | HEES, OLIVER DRAGON | 1628 | Non-Final OA | Dec 01, 2023 |
| 18566279 | SUBSTITUTED TETRAHYDROFURAN ANALOGS AS MODULATORS OF SODIUM CHANNELS | Vertex Pharmaceuticals Incorporated | BORALSKY, LUKE ALAN | 1624 | Non-Final OA | Dec 01, 2023 |
| 18566170 | PROCESS FOR THE SYNTHESIS OF SUBSTITUTED TETRAHYDROFURAN MODULATORS OF SODIUM CHANNELS | Vertex Pharmaceuticals Incorporated | HEES, OLIVER DRAGON | 1628 | Non-Final OA | Dec 01, 2023 |
| 18566176 | SOLID DOSAGE FORMS AND DOSING REGIMENS COMPRISING (2R,3S,4S,5R)-4-[[3-(3,4-DIFLUORO-2-METHOXY-PHENYL)-4,5-DIMETHYL-5-(TRIFLUOROMETHYL) TETRAHYDROFURAN-2-CARBONYL]AMINO]PYRIDINE-2-CARBOXAMIDE | Vertex Pharmaceuticals Incorporated | RAO, PADMAJA S | 1627 | Non-Final OA | Dec 01, 2023 |
| 18219384 | FACTOR B PROTEASES | Vertex Pharmaceuticals Incorporated | TSAY, MARSHA M | 1656 | Non-Final OA | Jul 07, 2023 |
| 17603827 | METHODS AND USES OF VARIANT ICOS LIGAND (ICOSL) FUSION PROTEINS | Alpine Immune Sciences, Inc. | STONEBRAKER, ALYSSA RAE | 1642 | Final Rejection | Oct 14, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial